It was a darn good year for venture-backed IPOs. Here are some of the standout details.
The largest VC-funded offering was also the most talked-about: Twitter. The San Francisco-based company raised nearly $2 billion in a November debut that marked the biggest social media offering since Facebook in May 2012. The stock has performed well post-IPO too, with shares up about 20% in mid-December from their initial closing price.
Other big deals
No venture-backed IPOs came close to rivaling Twitter in size. However, there were some big deals, including FireEye ($349 million IPO), Veeva Systems ($300 million), Tableau Software ($292 million) and Zulily ($290 million).
As of the end of November, a total of 78 venture-backed companies had gone public on U.S. exchanges in 2013. U.S., according to Thomson Reuters (publisher of VCJ). U.S. venture firms backed a dozen more companies that went public on overseas exchanges., according to Thomson Reuters.
Longest time to exit
Bluebird Bio, which went public in June, took 20.5 years to go from initial funding to exit, making it by far the longest-waiting company on the list. Second place went to Xoom, a provider of online money transfer services, which went public 14.7 years after its first round. After that came Xencor, a developer of drugs for asthma and allergies that took 14.5 years ago.
Shortest time to exit
Who says life science companies take a long time to exit? Artana Therapeutics, a developer of drugs for treating pets, went public just 2.5 years after raising its first venture round. Karyopharm Therapeutics, a developer of drugs for treating cancer and other diseases, had its IPO three years after initially closing on VC funding (although the company was founded in 2008.) On the Internet side, coupon site RetailMeNot made its stock market debut 3.2 years after disclosing its first round.
Photo of FireEye founder Ashar Aziz being lifted by company execs following the company’s debut on the Nasdaq exchange in New York, Sept. 20, 2013. REUTERS/Brendan McDermid.